Hot Topics

Guidance for Assessment and Monitoring of Suspected Monkeypox Virus Cases and Contacts

Click here to view guidance

As of May 27, 2022

Helping Families Find Formula During the Infant Formula Shortage

Last Reviewed May 19, 2022

To address infant formula shortages in the wake of Abbott Nutrition’s voluntary recall of certain powdered infant formulas, the Biden-Harris Administration is working to ensure that infant formula is safe and available for families across the country. Yesterday, President Biden spoke with retailers and manufacturers, including Walmart, Target, Reckitt, and Gerber, to discuss ways to get more formula quickly and safely onto store shelves. Read more

282007707_339073491662080_783269632081409658_n (1)

Powdered Infant Formula Recall

Date: February 17, 2022

The U.S. Food and Drug Administration announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections. All of the cases are reported to have consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, Michigan facility. As a result of the ongoing investigation, along with the U.S. Centers for Disease Control and Prevention and state and local partners, the FDA is alerting consumers to avoid purchasing or using certain powdered infant formula products produced at this facility. This is an ongoing investigation, and the firm is working with the FDA to initiate a voluntary recall of the potentially affected product.

The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:

  • the first two digits of the code are 22 through 37; and
  • the code on the container contains K8, SH or Z2; and
  • the expiration date is 4-1-2022 (APR 2022) or later.
  • The FDA is investigating complaints of four infant illnesses from three states. All four cases related to these complaints were hospitalized and Cronobacter may have contributed to a death in one case. The FDA has initiated an onsite inspection at the facility. Findings to date include several positive Cronobacter sakazakii results from environmental samples taken by the FDA and adverse inspectional observations by the FDA investigators. A review of the firm’s internal records also indicate environmental contamination with Cronobacter sakazakii and the firm’s destruction of product due to the presence of Cronobacter.

    For Participants who have recalled formula:

  • WIC formula cannot be returned to the store for a refund.
  • Participants should contact Similac 1-800-986-8540 or via Product Lookup (
  • The State WIC Office is continuing to have discussions with USDA and Abbott to address the issue.
  • Participants with SNAP benefits may use SNAP to purchase formula.
  • What if WIC Participants can’t find their regular product on the retail shelves:

  • If participants cannot find their regular formula on the shelf, we can issue concentrate or RTF if available.
  • For healthy infants on current contract Similac Products if they are unable to finds their product on the shelf:

  • You may issue the same formula in another form if available on retailer shelves.
  • If the other type of Similac formula is not available on retailer shelves, issue 1 month of comparable noncontract formula. Document in the medical record the reason for the change. For example, Food package change due to formula recall/shortage. Below is a list of Similac products and comparable noncontract formulas.
    • Advance- Good Start Gentle or Enfamil Infant
    • Total Comfort- Good Start Soothe or Enfamil Gentlease
    • Sensitive- Good Start Soothe or Enfamil
    • Spit Up – Enfamil AR
    • Isomil Soy- Good Start Soy or Enfamil ProSobee

    For participants on Alimentum, if they cannot find powdered formula on the retail shelves, you may issue RTF., if they are not able to locate either powered or RTF, advise them to contact their health care provider for a prescription for an appropriate product.

    For participants on Elecare, if they are not able to find product on the shelves, advise them to contact their health care provider for a prescription for an appropriate product.